131 related articles for article (PubMed ID: 6745804)
1. [Pharmacological action of mazindol on behaviors and metabolism].
Nagai K; Mori T; Ookura M; Tsujimoto H; Nakagawa H
Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):133-45. PubMed ID: 6745804
[TBL] [Abstract][Full Text] [Related]
2. Effect of mazindol on feeding behaviour and on noradrenergic function of various parts of the rat brain.
Halmy L; Nyakas C; Walter J
Acta Physiol Acad Sci Hung; 1982; 59(4):341-7. PubMed ID: 7170986
[TBL] [Abstract][Full Text] [Related]
3. Mazindol anorexia is mediated by activation of dopaminergic mechanisms.
Kruk ZL; Zarrindast MR
Br J Pharmacol; 1976 Nov; 58(3):367-72. PubMed ID: 990591
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol).
Gogerty JH; Penberthy C; Iorio LC; Trapold JH
Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):285-307. PubMed ID: 1171662
[TBL] [Abstract][Full Text] [Related]
5. [Effects of an anorexiant, mazindol, on metabolic abnormalities of rats with ventromedial hypothalamic lesions].
Inoue S; Egawa M; Satoh S
Nihon Yakurigaku Zasshi; 1984 May; 83(5):441-9. PubMed ID: 6469133
[TBL] [Abstract][Full Text] [Related]
6. [Changes in meal patterns and endogenous chemical determinants related to food intake following intra-ventricle III infusion of mazindol].
Fujimoto K; Sakata T; Arase K; Tsutsui K; Fukushima M
Nihon Yakurigaku Zasshi; 1984 May; 83(5):425-32. PubMed ID: 6381262
[TBL] [Abstract][Full Text] [Related]
7. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
[TBL] [Abstract][Full Text] [Related]
8. Changes in meal pattern and endogenous feeding related substances following mazindol administration.
Sakata T; Fujimoto K; Terada K; Arase K; Fukushima M
Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):11-28. PubMed ID: 6388520
[TBL] [Abstract][Full Text] [Related]
9. Mazindol: anorectic and behavioral effects in female rats.
Mattei R; Carlini EA
Arch Int Pharmacodyn Ther; 1995; 330(3):279-87. PubMed ID: 8836447
[TBL] [Abstract][Full Text] [Related]
10. Anorexiants modulate activity of feeding and gastric-related hypothalamic neurons.
Shiraishi T
Int J Obes; 1987; 11 Suppl 3():57-61. PubMed ID: 3440692
[No Abstract] [Full Text] [Related]
11. The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia.
Hillebrand JJ; Heinsbroek AC; Kas MJ; Adan RA
J Mol Endocrinol; 2006 Feb; 36(1):153-62. PubMed ID: 16461935
[TBL] [Abstract][Full Text] [Related]
12. Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.
Babbini M; Gaiardi M; Bartoletti M
Pharmacology; 1977; 15(1):46-56. PubMed ID: 557207
[TBL] [Abstract][Full Text] [Related]
13. Effects of the non-amphetaminergic anorexiant, mazindol, on neuronal activity and hypothalamic control of gastric acid secretion in rats.
Shiraishi T
Int J Obes; 1985; 9(4):285-97. PubMed ID: 3905642
[TBL] [Abstract][Full Text] [Related]
14. Anorectic drugs and vitamin C: role in appetite and brain ascorbic acid in guineapigs.
Odumosu A
Int J Vitam Nutr Res; 1981; 51(3):247-53. PubMed ID: 7319724
[TBL] [Abstract][Full Text] [Related]
15. Effects of anorectic drugs on the topography of feeding behavior in baboons.
Foltin RW
J Pharmacol Exp Ther; 1989 Apr; 249(1):101-9. PubMed ID: 2709326
[TBL] [Abstract][Full Text] [Related]
16. Systemic mazindol reduces food intake in rats via suppression of meal size and meal number.
Wellman PJ
J Psychopharmacol; 2008 Jul; 22(5):532-5. PubMed ID: 18208906
[TBL] [Abstract][Full Text] [Related]
17. Analysis of feeding suppression produced by perifornical hypothalamic injection of catecholamines, amphetamines and mazindol.
Leibowitz SF; Rossakis C
Eur J Pharmacol; 1978 Dec; 53(1):69-81. PubMed ID: 738361
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of mazindol in preventing onset and development of obesity induced by gold thioglucose injection.
Kawano-Takahashi Y; Ohminaji H; Ubagai E; Okuda H
Int J Obes; 1984; 8(6):655-64. PubMed ID: 6442712
[TBL] [Abstract][Full Text] [Related]
19. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic microdialysis of mazindol causes anorexia with increase in synaptic serotonin in rats.
Shimizu N; Take S; Hori T; Oomura Y
Physiol Behav; 1991 Jan; 49(1):131-4. PubMed ID: 2017466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
